Pemetrexed trials for Leptomeningeal Metastasis

All Pemetrexed trials · All Leptomeningeal Metastasis trials

Phase breakdown

Recruiting trials studying Pemetrexed for Leptomeningeal Metastasis

• Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir
  NCT06399926 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
  NCT06304441 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC
  NCT06663306 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.
  NCT06296745 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer
  NCT06431685 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Pemetrexed for Leptomeningeal Metastasis?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.